Smart for Life (SMFL) Competitors $0.04 0.00 (-2.17%) (As of 02:01 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SMFL vs. ASLN, ZVSA, ADXS, QLGN, NMTR, EVFM, PTEIQ, PXMD, CYCC, and BLPHShould you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include ASLAN Pharmaceuticals (ASLN), ZyVersa Therapeutics (ZVSA), Ayala Pharmaceuticals (ADXS), Qualigen Therapeutics (QLGN), 9 Meters Biopharma (NMTR), Evofem Biosciences (EVFM), PolarityTE (PTEIQ), PaxMedica (PXMD), Cyclacel Pharmaceuticals (CYCC), and Bellerophon Therapeutics (BLPH). These companies are all part of the "pharmaceutical products" industry. Smart for Life vs. ASLAN Pharmaceuticals ZyVersa Therapeutics Ayala Pharmaceuticals Qualigen Therapeutics 9 Meters Biopharma Evofem Biosciences PolarityTE PaxMedica Cyclacel Pharmaceuticals Bellerophon Therapeutics ASLAN Pharmaceuticals (NASDAQ:ASLN) and Smart for Life (NASDAQ:SMFL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, community ranking, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership. Which has higher valuation and earnings, ASLN or SMFL? Smart for Life has lower revenue, but higher earnings than ASLAN Pharmaceuticals. ASLAN Pharmaceuticals is trading at a lower price-to-earnings ratio than Smart for Life, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioASLAN Pharmaceuticals$12M0.10-$44.22M-$21.92-0.03Smart for Life$8.23M0.04-$22.68M-$1.12 thousand0.00 Do analysts recommend ASLN or SMFL? ASLAN Pharmaceuticals currently has a consensus price target of $76.00, suggesting a potential upside of 12,566.67%. Given ASLAN Pharmaceuticals' stronger consensus rating and higher possible upside, equities research analysts plainly believe ASLAN Pharmaceuticals is more favorable than Smart for Life.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ASLAN Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Smart for Life 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is ASLN or SMFL more profitable? Smart for Life's return on equity of 0.00% beat ASLAN Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets ASLAN PharmaceuticalsN/A -8,454.87% -121.60% Smart for Life N/A N/A N/A Does the MarketBeat Community believe in ASLN or SMFL? ASLAN Pharmaceuticals received 199 more outperform votes than Smart for Life when rated by MarketBeat users. However, 100.00% of users gave Smart for Life an outperform vote while only 63.49% of users gave ASLAN Pharmaceuticals an outperform vote. CompanyUnderperformOutperformASLAN PharmaceuticalsOutperform Votes20063.49% Underperform Votes11536.51% Smart for LifeOutperform Votes1100.00% Underperform VotesNo Votes Does the media refer more to ASLN or SMFL? In the previous week, Smart for Life's average media sentiment score of 0.26 beat ASLAN Pharmaceuticals' score of 0.00 indicating that Smart for Life is being referred to more favorably in the news media. Company Overall Sentiment ASLAN Pharmaceuticals Neutral Smart for Life Neutral Which has more volatility and risk, ASLN or SMFL? ASLAN Pharmaceuticals has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, Smart for Life has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Do insiders and institutionals hold more shares of ASLN or SMFL? 58.8% of ASLAN Pharmaceuticals shares are owned by institutional investors. Comparatively, 28.4% of Smart for Life shares are owned by institutional investors. 4.7% of ASLAN Pharmaceuticals shares are owned by company insiders. Comparatively, 31.7% of Smart for Life shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryASLAN Pharmaceuticals beats Smart for Life on 9 of the 16 factors compared between the two stocks. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Get Smart for Life News Delivered to You Automatically Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMFL vs. The Competition Export to ExcelMetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$319,000.00$1.29B$5.10B$8.84BDividend YieldN/AN/A5.04%4.07%P/E Ratio0.0029.6595.1214.22Price / Sales0.048.981,217.3088.42Price / CashN/A11.6239.4936.27Price / Book0.002.066.976.37Net Income-$22.68M-$52.95M$118.73M$225.56M7 Day PerformanceN/A-2.48%-1.22%-0.02%1 Month PerformanceN/A-1.88%-3.07%2.04%1 Year PerformanceN/A6.13%32.52%28.00% Smart for Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMFLSmart for LifeN/A$0.05-2.2%N/A-99.6%$319,000.00$8.23M0.00110Gap DownASLNASLAN Pharmaceuticals1.1723 of 5 stars$0.60flat$76.00+12,566.7%N/A$1.23M$12M-0.0330ZVSAZyVersa Therapeutics2.3628 of 5 stars$1.15flat$120.00+10,334.8%-95.9%$1.18MN/A0.002ADXSAyala PharmaceuticalsN/A$0.03-74.8%N/A-96.7%$1.15M$10,000.000.0020Analyst ForecastNews CoverageGap DownQLGNQualigen TherapeuticsN/A$4.41+14.0%N/A-89.1%$1.10M$4.98M0.0050News CoverageGap UpNMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A-0.0220EVFMEvofem Biosciences0.8097 of 5 stars$0.01flatN/A-85.3%$1.03M$18.22M-0.02120Gap UpPTEIQPolarityTEN/A$0.13flatN/A+50.1%$923,000.00$810,000.00-0.0460Gap DownPXMDPaxMedicaN/A$0.07-33.0%$3.00+4,173.5%-89.3%$794,000.00N/A0.002Gap DownCYCCCyclacel Pharmaceuticals2.1409 of 5 stars$0.35-5.7%$11.00+3,042.9%-91.7%$752,000.00$420,000.000.0014Gap DownBLPHBellerophon Therapeutics0.4751 of 5 stars$0.06+44.7%N/A+9.2%$673,000.00N/A0.0020 Related Companies and Tools Related Companies ASLAN Pharmaceuticals Competitors ZyVersa Therapeutics Competitors Ayala Pharmaceuticals Competitors Qualigen Therapeutics Competitors 9 Meters Biopharma Competitors Evofem Biosciences Competitors PolarityTE Competitors PaxMedica Competitors Cyclacel Pharmaceuticals Competitors Bellerophon Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SMFL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smart for Life, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smart for Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
